Category: Monthly Scientific Update
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Kelly-Butler-300x300.jpeg)
Monthly Scientific Update – May 2023
APOBEC3-Mediated Mutagenesis in Cholangiocarcinoma Many enzymes are involved in the immune response to viruses and APOBEC3s are a class of…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Kelly-Butler-300x300.jpeg)
Monthly Scientific Update – April 2023
Radiomics Models May Help Identify Candidates for Surgery Most cholangiocarcinoma tumors are unfortunately detected at advanced stages, but surgical resection…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Kelly-Butler-300x300.jpeg)
Monthly Scientific Update – March 2023
Asbestos and Cholangiocarcinoma: A Pilot Study Kelly Butler Asbestos is a mineral-derived carcinogen linked to multiple human cancers. Although asbestos…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Scientific-Article-Feb-23-300x197.png)
Monthly Scientific Update – February 2023
LCK Inhibitor: A Novel Potential Therapy for Cholangiocarcinoma A variety of signaling pathways can become overactive in cancer to promote…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Kelly-Butler-300x300.jpeg)
Monthly Scientific Update – January 2023
Apigenin-Conjugated Gold Nanoparticles: A Potential New Treatment for Cholangiocarcinoma Apigenin is a plant-derived compound that has been explored as a…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Kelly-Butler-300x300.jpeg)
Monthly Scientific Update – December 2022
The Oral Microbiome in Cholangiocarcinoma: A Potential Biomarker that Could Promote Early Detection Kelly Butler, Dr. Reham Abdel-Wahab The human…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Kelly-Butler-300x300.jpeg)
Monthly Scientific Update – November 2022 (A recent study investigated the effects of PD-L1 expression on cancer cells and tumor-infiltrating immune cells in intrahepatic cholangiocarcinoma (CCA))
PD-L1 on Tumor-Infiltrating Immune Cells: A Potential Prognostic Biomarker for Cholangiocarcinoma Kelly Butler, Dr. Reham Abdel-Wahab Patients may develop cancer…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Kelly-Butler-300x300.jpeg)
Monthly Scientific Update – October 2022 (Breath Tests Could Help Diagnose Cholangiocarcinoma: An Innovative Approach to Early Detection)
Kelly Butler, Dr. Reham Abdel-Wahab Cholangiocarcinoma (CCA) is often detected at an advanced stage that is difficult to treat. Early…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/Kelly-Butler-300x300.jpeg)
Monthly Scientific Update – September 2022 (Precision Therapeutics for Intrahepatic Cholangiocarcinoma)
Kelly Butler, Dr. Reham Abdel-Wahab The traditional chemotherapies gemcitabine and cisplatin have several side effects and have been used to…
![](https://cholangiocarcinoma.org/wp-content/uploads/2024/04/chart-1-300x230.png)
Monthly Scientific Update – September 2022 (Can bacteria help fight cancer?)
George Riddle, Dr. Reham Abdel-Wahab Bacteria live in our guts - in all of us. Some of them are good;…